NCT01726413View on ClinicalTrials.gov

A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients).

PHASE2CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Painful Diabetic Peripheral Neuropathy
Interventions
DRUG

GRC 17356

DRUG

Matching Placebo

Trial Locations (15)

12000

DADO Medical s.r.o, Prague

55116

Institute for Clinical Research and Development( IKFE-CRO GmbH BahnhofstraBe 8A), Mainz

110002

Maulana Azad Medical College & Associate Hospitals, New Delhi

411001

Jehangir Clinical development Centre Pvt Ltd, Pune

440012

Getwell Hospital and Research Centre, Nagpur

452010

TOTALL Diabetes Hormone Institute, Indore

560043

Bangalore Clinisearch, Bangalore

560078

Jnana Sanjeevani Medical Centre, Bangalore

590010

K.L.E.S Dr. Prabhakar Kore Hospital & Medical research Centre, Belagavi

625020

Arthur Asirvathma Hospital, Madurai

772 00

NeuroHelp s.r.o, Olomouc

Unknown

DADO Medical s.r.o, Říčany

600 013

MV Hospital for Diabetes (P) Ltd, Chennai

641 009

Kovai Diabetes Speciality Centre and Hospital, Coimbatore

M15 6SH

ICON Manchester CPU, Manchester

Sponsors
All Listed Sponsors
collaborator

Glenmark Pharmaceuticals S.A.

INDUSTRY

lead

Glenmark Pharmaceuticals Ltd. India

INDUSTRY

NCT01726413 - A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients). | Biotech Hunter | Biotech Hunter